These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21763682)

  • 1. Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network.
    Li Q; Wang W; Yamada T; Matsumoto K; Sakai K; Bando Y; Uehara H; Nishioka Y; Sone S; Iwakiri S; Itoi K; Utsugi T; Yasumoto K; Yano S
    Am J Pathol; 2011 Sep; 179(3):1483-93. PubMed ID: 21763682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.
    Ikuta K; Yano S; Trung VT; Hanibuchi M; Goto H; Li Q; Wang W; Yamada T; Ogino H; Kakiuchi S; Uehara H; Sekido Y; Uenaka T; Nishioka Y; Sone S
    Clin Cancer Res; 2009 Dec; 15(23):7229-37. PubMed ID: 19934291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model.
    Van TT; Hanibuchi M; Goto H; Kuramoto T; Yukishige S; Kakiuchi S; Sato S; Sakaguchi S; Dat le T; Nishioka Y; Akiyama S; Sone S
    Respirology; 2012 Aug; 17(6):984-90. PubMed ID: 22574723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin and Hepatocyte Growth Factor Produced by Lung Fibroblasts Augment Migration and Invasion of Malignant Pleural Mesothelioma Cells.
    Kanaji N; Kita N; Kadowaki N; Bandoh S
    Anticancer Res; 2017 May; 37(5):2393-2400. PubMed ID: 28476806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
    Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
    J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.
    Li Q; Yano S; Ogino H; Wang W; Uehara H; Nishioka Y; Sone S
    Clin Cancer Res; 2007 Oct; 13(19):5918-25. PubMed ID: 17908988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
    Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
    Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.
    Van TT; Hanibuchi M; Kakiuchi S; Sato S; Kuramoto T; Goto H; Mitsuhashi A; Nishioka Y; Akiyama S; Sone S
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):497-504. PubMed ID: 21079960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES-10 cells) highly expressing vascular endothelial growth factor and its receptor.
    Nakataki E; Yano S; Matsumori Y; Goto H; Kakiuchi S; Muguruma H; Bando Y; Uehara H; Hamada H; Kito K; Yokoyama A; Sone S
    Cancer Sci; 2006 Mar; 97(3):183-91. PubMed ID: 16542214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target.
    Huang J; Tabata S; Kakiuchi S; The Van T; Goto H; Hanibuchi M; Nishioka Y
    Oncotarget; 2013 Aug; 4(8):1172-84. PubMed ID: 23896451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-Associated Fibroblasts Regulate Kinase Activity in Mesothelioma Cell Lines via Paracrine Signaling and Thereby Dictate Cell Faith and Behavior.
    Mathilakathu A; Wessolly M; Mairinger E; Uebner H; Kreidt D; Brcic L; Steinborn J; Greimelmaier K; Wohlschlaeger J; Schmid KW; Mairinger FD; Borchert S
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice.
    Tabata C; Tabata R; Hirayama N; Yasumitsu A; Yamada S; Murakami A; Iida S; Tamura K; Terada T; Kuribayashi K; Fukuoka K; Nakano T
    Eur Respir J; 2009 Nov; 34(5):1159-67. PubMed ID: 19443527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation.
    Takeuchi S; Fukuda K; Yamada T; Arai S; Takagi S; Ishii G; Ochiai A; Iwakiri S; Itoi K; Uehara H; Nishihara H; Fujita N; Yano S
    Cancer Sci; 2017 Apr; 108(4):696-703. PubMed ID: 28182302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular protease imaging for cell mass tracking of xenografted human malignant pleural mesothelioma.
    Zhou L; El-Deiry W; Wang W; Ingram ME; Katz SI
    Oncol Rep; 2012 Sep; 28(3):883-8. PubMed ID: 22751990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
    Jänne PA; Taffaro ML; Salgia R; Johnson BE
    Cancer Res; 2002 Sep; 62(18):5242-7. PubMed ID: 12234991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapleural Adenoviral-mediated Endothelial Cell Protein C Receptor Gene Transfer Suppresses the Progression of Malignant Pleural Mesothelioma in a Mouse Model.
    Keshava S; Rao LV; Pendurthi UR
    Sci Rep; 2016 Nov; 6():36829. PubMed ID: 27833109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells.
    Yamaji M; Ota A; Wahiduzzaman M; Karnan S; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y; Haniuda M
    Cancer Med; 2017 Nov; 6(11):2646-2659. PubMed ID: 28960945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma.
    Jagadeeswaran R; Ma PC; Seiwert TY; Jagadeeswaran S; Zumba O; Nallasura V; Ahmed S; Filiberti R; Paganuzzi M; Puntoni R; Kratzke RA; Gordon GJ; Sugarbaker DJ; Bueno R; Janamanchi V; Bindokas VP; Kindler HL; Salgia R
    Cancer Res; 2006 Jan; 66(1):352-61. PubMed ID: 16397249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma.
    Borchert S; Suckrau PM; Walter RFH; Wessolly M; Mairinger E; Steinborn J; Hegedus B; Hager T; Herold T; Eberhardt WEE; Wohlschlaeger J; Aigner C; Bankfalvi A; Schmid KW; Mairinger FD
    Sci Rep; 2020 Oct; 10(1):18677. PubMed ID: 33122816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effect and antiangiogenic potential of the mTOR inhibitor temsirolimus against malignant pleural mesothelioma.
    Moriya M; Yamada T; Tamura M; Ishikawa D; Hoda MA; Matsumoto I; Klepetko W; Oda M; Yano S; Watanabe G
    Oncol Rep; 2014 Mar; 31(3):1109-15. PubMed ID: 24378576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.